Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
STI - Solidion Technology Inc - Stock Price Chart
TickerSTI [NASD]
CompanySolidion Technology Inc
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap59.79MEPS (ttm)-4.05
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y2.60%
P/B-EPS Q/Q-12377.42%
Dividend-Sales Q/Q-
Insider Own78.31%Inst Own2.01%
Insider Trans0.00%Inst Trans0.59%
Short Float4.96%EarningsApr 12/b
Analyst Recom-Target Price-
Avg Volume1.92M52W Range0.37 - 13.85
Jun-07-24 12:52PM STI Stock Earnings: Solidion Technology Reported Results for Q1 2024 (InvestorPlace) -7.45%
08:00AM Solidion Technology Reports Results for Q1 2024 (GlobeNewswire)
Jun-06-24 07:08PM Solidion Technology Announces Receipt of Expected Delinquency Notification Letter From Nasdaq Relating to Non-Compliance with Listing Rule 5250(c)(1) (GlobeNewswire) -5.05%
May-07-24 08:30AM Solidion's BEEP Platform Solves the Design and Manufacturing Issues of Solid-State Batteries (GlobeNewswire)
Apr-12-24 09:00AM Solidion Technology Reports Results for Full Year 2023 (GlobeNewswire) -7.67%
Mar-18-24 08:14AM Why Is Solidion Technology (STI) Stock Up 55% Today? (InvestorPlace) +56.32%
Mar-13-24 09:08PM Solidion Technology, Inc. Announces Pricing of $3.85 Million Private Placement (GlobeNewswire) -13.19%
Mar-11-24 04:12PM Why Is Solidion Technology (STI) Stock Up 125% Today? (InvestorPlace) +125.75% -17.71%
Mar-06-24 09:00AM Solidion Technologys Lithium-Sulfur Batteries on a Launch Pad to Accelerate the Takeoff of the eVTOL Aircraft Industry (GlobeNewswire)
Feb-27-24 09:00AM Extending the Driving Range without Increasing EV Weight? Yes, Solidion Technology, Inc. Provides Solutions (GlobeNewswire) -5.12%
ZNTL - Zentalis Pharmaceuticals Inc - Stock Price Chart
TickerZNTL [NASD, RUT]
CompanyZentalis Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap293.98MEPS (ttm)-3.36
P/E-EPS this Y39.51%
Forward P/E-EPS next Y-34.28%
PEG-EPS past 5Y-50.05%
P/S7.25EPS next 5Y-
P/B0.64EPS Q/Q113.26%
Dividend-Sales Q/Q-
Insider Own12.31%Inst Own113.65%
Insider Trans-0.48%Inst Trans-0.93%
Short Float28.13%EarningsMay 07/b
Analyst Recom2.20Target Price12.11
Avg Volume653.22K52W Range8.25 - 30.53
Jun-18-24Downgrade Wells Fargo Overweight → Equal Weight
Jun-18-24Downgrade Wedbush Neutral → Underperform $15 → $4
Jun-18-24Downgrade Morgan Stanley Overweight → Equal-Weight $38 → $8
Jun-18-24Downgrade Jefferies Buy → Hold $42 → $6
Today 04:52AM FDA places partial clinical hold on Zentalis trials of azenosertib for cancer (Clinical Trials Arena)
Jun-18-24 07:00AM Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program (GlobeNewswire) -50.66%
Jun-03-24 06:00PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-01-24 02:43AM Insider Selling at Zentalis Pharmaceuticals Inc (ZNTL): President, Interim CFO Cam Gallagher ... (GuruFocus.com)
May-30-24 07:00AM Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-29-24 07:00AM Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors (GlobeNewswire)
May-23-24 05:01PM Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting (GlobeNewswire) -5.84%
May-14-24 07:00AM Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit (GlobeNewswire)
May-08-24 10:27AM Stifel Adjusts Price Target on Zentalis Pharmaceuticals to $32 From $36, Maintains Buy Rating (MT Newswires)
May-07-24 09:04PM Zentalis Pharmaceuticals Reports Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic ... (GuruFocus.com) +5.03%
AWIN - AERWINS Technologies Inc - Stock Price Chart
TickerAWIN [NASD]
CompanyAERWINS Technologies Inc
CountryUSA
IndustryScientific & Technical Instruments
Market Cap1.60MEPS (ttm)-9.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.26EPS next 5Y-
P/B-EPS Q/Q407.08%
Dividend-Sales Q/Q-
Insider Own21.91%Inst Own1.09%
Insider Trans0.00%Inst Trans-20.28%
Short Float13.85%Earnings-
Analyst Recom1.00Target Price100.00
Avg Volume1.16M52W Range2.12 - 74.40
Jun-18-24 08:19AM Why Is Aerwins Technologies (AWIN) Stock Down 54% Today? (InvestorPlace) -47.90%
07:37AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-29-24 07:39AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) -38.73%
May-28-24 10:52PM AWIN Stock Earnings: AERWINS Technologies Reported Results for Q1 2024 (InvestorPlace) +143.09%
May-16-24 07:34AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) -18.47%
May-15-24 02:31PM Is Aerwins Technologies (AWIN) Stock the Next Big Short Squeeze? (InvestorPlace) +131.73%
Apr-23-24 05:15PM AERWINS Technologies Announces Additional Staff Determination (GlobeNewswire) -5.13% -16.52%
Mar-28-24 11:25AM AERWINS Technologies Announces 1-For-100 Reverse Stock Split (GlobeNewswire) -12.90%
Dec-04-23 07:21AM 10 Best Debt Free Penny Stocks To Buy Now (Insider Monkey)
Oct-24-23 08:41AM Why Is Aerwins Technologies (AWIN) Stock Up 26% Today? (InvestorPlace) +8.51%
TRNR - Interactive Strength Inc - Stock Price Chart
TickerTRNR [NASD]
CompanyInteractive Strength Inc
CountryUSA
IndustryPersonal Services
Market Cap2.07MEPS (ttm)-126.69
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.77EPS next 5Y-
P/B27.53EPS Q/Q50.54%
Dividend-Sales Q/Q131.21%
Insider Own-Inst Own0.45%
Insider Trans-Inst Trans-
Short Float-EarningsApr 02/b
Analyst Recom1.00Target Price60.00
Avg Volume726.05K52W Range2.64 - 158.00
Jun-18-24 07:37AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) -34.08%
07:00AM Interactive Strength Inc. (Nasdaq: TRNR) and Woodway Successfully Complete CLMBR Group Fitness Pilot With Crunch Fitness (NewMediaWire)
Jun-17-24 11:24AM Interactive Strength (TRNR) Stock Surges 129% After Reverse Stock Split (InvestorPlace) +70.73%
Jun-11-24 07:00AM Interactive Strength Inc. (Nasdaq: TRNR) Announces 1-for-40 Reverse Split (NewMediaWire)
May-22-24 04:15PM Interactive Strength Inc. (Nasdaq: TRNR) Announces Closing of $1 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules (NewMediaWire) -5.84%
May-21-24 09:53AM TRNR Stock Earnings: Interactive Strength Reported Results for Q1 2024 (InvestorPlace)
08:00AM Interactive Strength Inc. (Nasdaq: TRNR) Announces $1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (NewMediaWire)
May-20-24 05:58PM Interactive Strength Inc. (Nasdaq: TRNR) Reports First Quarter 2024 Results (NewMediaWire)
Apr-26-24 07:00AM Interactive Strength Inc. (Nasdaq: TRNR) Strengthens Balance Sheet by Partially Converting Senior Loan to Equity and Extending the Maturity (GlobeNewswire)
Apr-10-24 07:00AM Interactive Strength Inc. (Nasdaq: TRNR) to Exhibit CLMBR at FIBO Global Fitness, the World's Largest Trade Show for Fitness, Wellness and Health on April 11-14 (GlobeNewswire)
LPCN - Lipocine Inc - Stock Price Chart
TickerLPCN [NASD]
CompanyLipocine Inc
CountryUSA
IndustryBiotechnology
Market Cap38.41MEPS (ttm)-1.72
P/E-EPS this Y68.15%
Forward P/E-EPS next Y94.00%
PEG-EPS past 5Y19.47%
P/S5.01EPS next 5Y-
P/B1.59EPS Q/Q186.73%
Dividend-Sales Q/Q13751.93%
Insider Own2.91%Inst Own8.94%
Insider Trans0.00%Inst Trans-63.19%
Short Float3.01%EarningsMay 09/b
Analyst Recom1.00Target Price33.00
Avg Volume74.27K52W Range2.31 - 10.85
Jun-10-24 08:00AM Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024 (PR Newswire) +6.12%
Jun-06-24 08:50AM Lipocine (LPCN) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
May-28-24 06:10AM 7 Penny Biotech Stocks to Triple Your Investment (InvestorPlace)
May-21-24 08:50AM Here's Why Momentum in Lipocine (LPCN) Should Keep going (Zacks)
May-09-24 01:53PM LPCN Stock Earnings: Lipocine Beats EPS for Q1 2024 (InvestorPlace) +8.04%
08:00AM Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024 (PR Newswire)
06:24AM Lipocine: Q1 Earnings Snapshot (Associated Press Finance)
May-08-24 08:00AM Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024 (PR Newswire)
May-01-24 08:00AM Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154 (PR Newswire)
Apr-11-24 07:00AM Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity (PR Newswire)
TSHA - Taysha Gene Therapies Inc - Stock Price Chart
TickerTSHA [NASD]
CompanyTaysha Gene Therapies Inc
CountryUSA
IndustryBiotechnology
Market Cap555.45MEPS (ttm)-1.16
P/E-EPS this Y56.63%
Forward P/E-EPS next Y-14.28%
PEG-EPS past 5Y-137.69%
P/S39.23EPS next 5Y-
P/B10.32EPS Q/Q62.67%
Dividend-Sales Q/Q-27.52%
Insider Own25.20%Inst Own69.91%
Insider Trans0.00%Inst Trans-1.76%
Short Float11.53%EarningsMay 14/a
Analyst Recom1.10Target Price6.95
Avg Volume2.55M52W Range0.50 - 4.32
Jun-18-24 07:30AM Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome (GlobeNewswire) -26.30%
07:02AM Sanofi taps Belharra for immune drug research; AstraZenecas new cancer drug falls short (BioPharma Dive)
Jun-12-24 07:00AM Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting (GlobeNewswire)
Jun-07-24 08:00AM Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-03-24 04:31PM Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company? (Insider Monkey) +5.54%
04:17PM 9 Best Gene Therapy Stocks to Buy Now (Insider Monkey)
May-15-24 03:11AM Taysha Gene Therapies Inc (TSHA) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com) +21.01%
May-14-24 08:57PM TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +7.08%
05:15PM Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
05:03PM Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours (MT Newswires)
QXO - QXO Inc. - Stock Price Chart
TickerQXO [NASD]
CompanyQXO Inc.
CountryUSA
IndustrySoftware - Application
Market Cap60.57MEPS (ttm)-1.85
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.09EPS next 5Y-
P/B8.01EPS Q/Q-50.79%
Dividend-Sales Q/Q9.96%
Insider Own0.03%Inst Own20.40%
Insider Trans-99.92%Inst Trans361.03%
Short Float6.35%Earnings-
Analyst Recom1.00Target Price5.00
Avg Volume15.43K52W Range19.12 - 290.00
Jun-14-24 07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) -34.66%
Jun-13-24 07:42PM Correction: QXO Announces $3.5 Billion Private Placement (GlobeNewswire) +14.55%
07:00PM QXO Announces $3.5 Billion Private Placement (GlobeNewswire)
Jun-12-24 06:00AM Merger Mania: 3 Stocks to Buy as Industries Consolidate (InvestorPlace)
Jun-06-24 11:49AM QXO Announces Leadership Team and Board of Directors (GlobeNewswire) +68.61%
Jun-05-24 09:07AM Why Is SilverSun Technologies (SSNT) Stock Down 20% Today? (InvestorPlace)
07:35AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
03:03AM Insider Sale: CEO Mark Meller Sells Shares of SilverSun Technologies Inc (SSNT) (GuruFocus.com)
May-30-24 10:45AM SilverSun Stockholders Approve Equity Investment (ACCESSWIRE)
May-28-24 02:54PM Billionaire-Led QXO Hires Barclays Banker Ihsan Essaid as First Finance Chief (Bloomberg) +10.82%
NGNE - Neurogene Inc - Stock Price Chart
TickerNGNE [NASD]
CompanyNeurogene Inc
CountryUSA
IndustryBiotechnology
Market Cap393.55MEPS (ttm)-2.65
P/E-EPS this Y-241.98%
Forward P/E-EPS next Y1.52%
PEG-EPS past 5Y-16.09%
P/S-EPS next 5Y25.10%
P/B2.28EPS Q/Q-290.56%
Dividend-Sales Q/Q-
Insider Own10.33%Inst Own83.69%
Insider Trans0.00%Inst Trans-32.38%
Short Float8.40%EarningsMay 10/b
Analyst Recom1.17Target Price51.00
Avg Volume113.72K52W Range12.20 - 53.00
Jun-18-24 09:26AM Neurogene Announces First Patient Dosed in High-Dose Cohort of NGN-401 Gene Therapy Clinical Trial for Rett Syndrome (Business Wire) -24.20%
Jun-05-24 07:30AM Neurogene to Participate in Upcoming Conferences (Business Wire)
Jun-03-24 07:30AM Neurogene Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for START Pilot Program (Business Wire)
May-10-24 01:54PM NGNE Stock Earnings: Neurogene Beats EPS for Q1 2024 (InvestorPlace)
07:30AM Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates (Business Wire)
May-07-24 06:19AM Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome during ASGCT Annual Meeting (Business Wire)
Apr-22-24 04:36PM Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting (Business Wire)
Mar-20-24 05:31AM Neurogene Inc (NGNE) Reports Financial Results for Q4 and Full Year 2023 (GuruFocus.com)
Mar-18-24 04:14PM Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates (Business Wire) +20.00%
Mar-04-24 07:30AM Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial (Business Wire) +20.47%
ZAPP - Zapp Electric Vehicles Group Ltd - Stock Price Chart
TickerZAPP [NASD]
CompanyZapp Electric Vehicles Group Ltd
CountryUnited Kingdom
IndustryAuto Manufacturers
Market Cap4.26MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-7.52%
Dividend-Sales Q/Q-
Insider Own53.15%Inst Own8.08%
Insider Trans0.00%Inst Trans-
Short Float1.53%Earnings-
Analyst Recom-Target Price-
Avg Volume1.14M52W Range0.70 - 53.80
Jun-17-24 07:40AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -17.51%
Jun-14-24 09:37AM New to The Street Announces Episode 577, Six Corporate Interviews, Airing as a Sponsored Program on Bloomberg TV, Saturday, June 15, 2024, at 6:30 PM ET (GlobeNewswire) -10.70%
07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jun-13-24 09:25AM Zapp EV to Appoint Contract Manufacturing Partner for Sales of i300 in India (GlobeNewswire) +239.86%
May-10-24 10:16AM New to The Street Airs Corporate Interviews, Televised Episodes 573 and 574 as Sponsored Programming on Bloomberg TV and The FOX Business Network (GlobeNewswire)
May-06-24 09:30AM New to The Street Airs Episode 572 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network, Monday, May 6, 2024, at 10:30 PM PT (GlobeNewswire)
Apr-30-24 07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) -7.94%
Apr-26-24 09:16AM 11 Best EV Penny Stocks to Buy (Insider Monkey)
Apr-18-24 09:00AM New to The Street Signs Zapp EV to 6 Part Media Series, Agreement Includes Commercials and Billboard Ads (GlobeNewswire) -10.36%
Apr-17-24 08:00AM Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on April 18, 2024 (GlobeNewswire) -33.45%
SCNI - Scinai Immunotherapeutics Ltd ADR - Stock Price Chart
TickerSCNI [NASD]
CompanyScinai Immunotherapeutics Ltd ADR
CountryIsrael
IndustryBiotechnology
Market Cap1.99MEPS (ttm)-20.17
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y46.35%
P/S-EPS next 5Y-
P/B-EPS Q/Q-185.60%
Dividend-Sales Q/Q-
Insider Own2.25%Inst Own8.83%
Insider Trans0.00%Inst Trans-
Short Float0.97%EarningsMay 15/a
Analyst Recom1.00Target Price700.00
Avg Volume514.85K52W Range2.23 - 18.70
Jun-17-24 07:56AM Why Is Scinai Immunotherapeutics (SCNI) Stock Up 88% Today? (InvestorPlace) +60.46%
07:40AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
Jun-13-24 07:00AM Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity (PR Newswire)
Jun-07-24 07:00AM Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement (PR Newswire) -28.41%
Jun-03-24 10:52AM SCNI Stock Earnings: Scinai Immunotherapeutics Reported Results for Q4 2023 (InvestorPlace) -5.33%
May-24-24 04:01PM Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance (PR Newswire) +12.46% -9.42%
May-15-24 04:01PM Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update (PR Newswire)
May-06-24 09:21AM Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal (PR Newswire)
Apr-10-24 07:00AM Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schn of UMG (PR Newswire)
Apr-08-24 07:00AM Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services (PR Newswire)
123456⋯10⋯20
affiliate • advertise • careers • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.